Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. (RLMD) stock FAQs
Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.
What is Relmada Therapeutics, Inc. (RLMD) stock price today?
As of Dec 15, 2025, 8:59 PM UTC, Relmada Therapeutics, Inc. (RLMD) stock is trading at $4.36. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date RLMD stock quotes for informed trading decisions.
What is Relmada Therapeutics, Inc.'s market capitalization?
Relmada Therapeutics, Inc. (RLMD) has a market capitalization of approximately $319.6M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Relmada Therapeutics, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the RLMD stock price changes.
What is the 52-week range for Relmada Therapeutics, Inc. stock?
Relmada Therapeutics, Inc. (RLMD) stock has traded in a 52-week range of $0.24 — $5.12. The 52-week range shows the highest and lowest prices at which RLMD traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Relmada Therapeutics, Inc. stock price to this range provides context for recent price action.
How much trading volume does Relmada Therapeutics, Inc. stock have?
Relmada Therapeutics, Inc. (RLMD) stock recently traded approximately 595.7K shares. Trading volume indicates market liquidity and investor interest in RLMD. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Relmada Therapeutics, Inc. stock.
Does Relmada Therapeutics, Inc. pay dividends to shareholders?
Yes, Relmada Therapeutics, Inc. (RLMD) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Relmada Therapeutics, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.
What is Relmada Therapeutics, Inc.'s intraday price range?
Today, Relmada Therapeutics, Inc. (RLMD) stock has traded in a range of $4.01 — $4.45. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring RLMD's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.
Where does AlphaPilot get Relmada Therapeutics, Inc. stock data?
AlphaPilot sources real-time RLMD stock quotes, fundamental financial data, and historical price charts for Relmada Therapeutics, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Relmada Therapeutics, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of RLMD stock performance.